EED-226

Target: This ligand targets embryonic ectoderm development protein EED within the PRC2 complex in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for embryonic ectoderm development protein EED within the PRC2 complex. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings embryonic ectoderm development protein EED within the PRC2 complex into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• EED-226 as E3 Ligase Ligand: EED-226 can be used to build PROTACs that recruit EED-containing complexes to the ubiquitin-proteasome system. By coupling EED-226 to an appropriate target-binding moiety, researchers can probe whether induced proximity drives selective degradation of epigenetic regulators and downstream transcriptional programs.

• Targeted Degradation of EED Complex: PROTAC designs incorporating EED-226 enable systematic evaluation of EED-dependent complex stability. Researchers can vary linker length and attachment geometry to optimize ternary complex formation, aiming to achieve robust degradation of EED-associated proteins and to dissect how degradation versus inhibition alters chromatin-associated phenotypes.

• Mapping Ternary Complex Requirements: EED-226-based PROTACs support mechanistic studies of degrader efficiency by enabling controlled comparisons across target ligands. Measuring degradation kinetics, ubiquitination, and dependence on proteasome activity helps define the structural and biochemical parameters required for productive EED engagement and effective target protein turnover.

• Epigenetic Pathway Perturbation: Using EED-226 in PROTAC constructs allows targeted disruption of epigenetic signaling networks governed by EED-linked pathways. This approach is valuable for determining how selective protein degradation impacts histone mark maintenance, gene expression, and cell-state transitions compared with conventional occupancy-based inhibitors.

• Proteomics-Guided Degradation Profiling: EED-226-derived PROTACs can be employed to generate degradation signatures using quantitative proteomics. By profiling on- and off-target effects under controlled PROTAC exposure, researchers can refine ligand selection and degrader architecture to enhance specificity and identify biomarkers of EED-proximal degradation events.

EED-226 is an EED-binding ligand scaffold for EED-directed degrader research. Linker-ready analogs should preserve the triazolopyrimidine recognition core while adding a tolerated exit vector.

Structure: EED-226 is an EED ligand containing a triazolopyrimidine core, furanmethylamino substituent, and methylsulfonylphenyl group. The molecule presents a compact heteroaromatic recognition scaffold with sulfone, furan, and aminopyrimidine-like hydrogen-bonding features.

Reactivity: EED-226 can guide EED-targeted PROTAC design, but the parent structure lacks a clear free acid or primary amine handle for direct coupling. Linker-ready analogs should introduce a tolerated vector on the aryl sulfone, furanmethylamino, or peripheral heteroaryl region while preserving the triazolopyrimidine EED-recognition core. Alkyl, PEG, amide, ether, or sulfonamide-compatible linkers can be paired with CRBN, VHL, or IAP ligands after validating EED engagement.